Skip to content

Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria.

Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07110935
Enrollment
290
Registered
2025-08-08
Start date
2018-09-13
Completion date
2019-02-20
Last updated
2025-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Anaemia

Brief summary

Background:Anaemia is a condition of public health importance.Iron deficiency anaemia is the most common cause of anaemia in pregnancy.Postpartum anaemia poses a significant role for postpartum morbidity and mortality and should be treated.Postpartum iron deficiency anaemia warrants greater attention and higher quality of care.Oral iron treatment has been considered the standard of care. However,parenteral iron treatment is expected to be advantageous in cases where oral iron therapy is not possible.As a result,there is increased interest in parenteral iron therapy. Objectives:To determine the effect of treatment of postpartum anaemia with intravenous versus oral iron therapy at Federal Medical Centre,Umuahia. Materials and Method:This study is a prospective randomized controlled study carried out in department of Obstetric and Gynaecology, Federal Medical Centre,Umuahia,the capital of Abia State,South-east, Nigeria. The study population comprised of postpartum women with mild to moderate anaemia within 48 hours of delivery who were randomized into two groups.One group will be given oral iron therapy and the other intravenous iron dextran.Response and comparative effects of treatment using either route of administration were assessed at 6 weeks postpartum.The biodata,obstetric characteristics and haemoglobin estimation of the respondents were recorded on a structured study proforma.The data obtained from the study was analyzed with the statistical package for the social sciences(SPSS) software.Continuous variables obtained from this study were expressed as mean and standard deviation while categorical variables were summarized using frequency and percentages.Association between categorical variables were done using chi square.P-value less than 0.05 was taken as significant.

Interventions

intravenous iron dextran

oral iron(ferrous Sulphate)

Sponsors

Federal Teaching Hospital Abakaliki
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

* Women who have vaginal delivery of singleton baby and are seen within 48hours of childbirth * Women with mild and moderate anaemia * Women who gave their consent to participate in the study.

Exclusion criteria

* Women with severe anaemia * Women with multiple pregnancy * Women with genotype HbSS * Women with HIV infection * Women who delivered by caesarean section * Women with co-morbidity like hypertensive disorders, renal pathology * Women who decline consent after adequate counseling. * Previous and current history of adverse reaction to iron dextran

Design outcomes

Primary

MeasureTime frame
Mean postpartum haematocritSix weeks
Mean hematocrit following treatment with iron dextranSix weeks

Secondary

MeasureTime frame
Incidence and patterns of postpartum anaemiaSix weeks

Countries

Nigeria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026